CVS Caremark cuts off Walgreen from retail pharmacy network starting next monthBy AP
Wednesday, June 9, 2010
CVS Caremark to cut off Walgreen from network
NEW YORK — CVS Caremark Corp. said Wednesday it will end rival Walgreen Co.’s participation in its retail pharmacy network starting in a month.
The move would mean that people whose prescription drug benefits are handled by Caremark would not be able to be reimbursed for prescriptions filled at Walgreen pharmacies. Walgreen said it expects most of its 7,500 stores to be out of Caremark’s commercial network in 30 days. Some Walgreen stores won’t be cut off as quickly because of state laws or client contracts.
The Woonsocket, R.I., pharmacy benefits manager also said it will end Walgreen’s participation in its Medicare Part D retail pharmacy network on Jan. 1.
Walgreen, based in Deerfield, Ill., is the largest U.S. drugstore chain based on locations and revenue, slightly ahead of CVS Caremark. Caremark is one of the largest pharmacy benefits management networks. It negotiates contracts with employers and handles the drug benefit part of their health plans, paying pharmacies to fill prescriptions. It saves money by negotiating volume discounts.
Walgreen wants to be paid more for filling prescriptions, while Caremark makes money by reducing costs for plan members and sponsors. The companies had been in negotiations for months, although CVS now says Walgreen refused to negotiate in good faith.
Walgreen CEO Greg Wasson said in an interview that the company decided it did not make sense to continue doing business with Caremark. Walgreen said Monday that was because Walgreen wants better prices and objects to policies that drive customers to CVS stores. Walgreen said it would honor any current contracts, however, so customers would have felt few effects until 2012.
CVS Caremark said that move was a transparent attempt to raise reimbursement rates. It said consumer access to pharmacies won’t be much changed even without Walgreen.
According to Citi Investment Research analyst Garen Sarafian, about 13 percent of drugstores nationwide are run by Walgreen. The company said it fills almost 20 percent of all retail prescriptions in the U.S.
Sarafian and other analysts think the companies will eventually renegotiate their reimbursement rates because Walgreen does not want to lose the revenue it gets from Caremark, and Caremark does not want to lose contracts to other PBMs. However, a resolution might take months, and Caremark’s biggest rivals, Medco Health Solutions Inc. and Express Scripts Inc., will get more business from clients who decide not to participate in a network that excludes the biggest drugstore chain the country.
Sarafian thinks Medco, in particular, will benefit from the split, which comes as the pharmacy benefits managers are trying to secure contracts that will start in 2011.
Walgreen gets about 7 percent of its revenue from Caremark prescriptions, or about $4.5 billion in its last fiscal year. Wasson said about one out in 10 people who use Walgreen pharmacies have Caremark coverage. Caremark says its plans serve 53 million individuals — known as covered lives — and it handled almost 660 million prescriptions for those people in 2009.
So far, Wall Street appears to believe that CVS has more to lose in the dispute, as its shares are down about 9 percent this week and Walgreen shares have lost about 3 percent. But Moody’s Investors Service reduced its outlook on Walgreen’s credit to ‘negative’ from ’stable,’ and did not change its view on CVS Caremark.
Moody’s said Walgreen could lose customers, which would reduce its pharmacy revenue and sales of other items. The firm said Walgreen may have trouble making up for lost Caremark revenue, which would hurt its credit.
In a statement, Walgreen said in response to the CVS announcement that it was “disappointed but not surprised” by the decision. Walgreen said the move confirms its view that doing business with Caremark was not in its best interest. It said it is confident its business will continue to grow as it participates in PBM networks and provides other services directly to employers.
Walgreen shares fell 78 cents, or 2.6 percent, to $29.83 in Wednesday trading, while CVS shares dropped 49 cents to $30.67.
Associated Press Writer Tom Murphy in Indianapolis contributed to this story.
Tags: Health Care Industry, New York, North America, Rhode Island, United States, Woonsocket